Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Fund of hedge funds manager Liongate increases US presence, hires Director of Investment Research

Tuesday, July 12, 2011
Opalesque Industry Update - Liongate Capital Management (Liongate) the global fund of hedge funds manager, today announced the appointment of Richard ‘Rick’ Teisch as US Director of Investment Research. He will be based in Liongate’s US office in the Carnegie Hall Towers in midtown Manhattan, and will coordinate the expansion of Liongate’s US-based investment research activity.

Liongate is recognised by international institutional investors for its dynamic top-down strategy asset allocation and its diversified portfolio construction of mid-sized investment managers,” said Jeff Holland, Managing Director, Liongate Capital Management. “Expanding our presence in the US will enable us to be in closer communication with our American investors. Investment research will also be closer to our American investment managers, further sharpening our focus on high risk-adjusted returns for our clients.”

Rick Teisch was previously a Managing Director at Cliffwater, one of the largest alternatives consulting and advisory firms in the US, where he headed equity long/short research. Teisch has also held senior analyst roles with Paradigm Consulting Services, Hennessee Group and Public Service Enterprise Group. He studied first at the University of Delaware and holds a Master of Business Administration from Seton Hall University.

Randall Dillard, Chief Investment Officer, Liongate Capital Management, said, "Rick is a smart, highly experienced investment professional. His appointment underlines our commitment to providing our clients with the best investment solutions in the US and globally."

(press release)


Liongate Capital Management is an independent fund of hedge funds manager focused on creating and managing fund of hedge fund investment solutions for institutional and private investors. Liongate is a multi-billion dollar manager of fund of hedge funds, managed accounts, and customized investment portfolios for institutional investors and sovereign wealth funds.Liongate has received numerous investment awards, including HFMWeek ‘Fund of Hedge Funds over US$1bn’ (2011), Institutional Investor 'Fund of Hedge Funds Leader of the Year' (2009); InvestHedge 'Best Global Multi-Strategy Fund over US$1bn' (2009) and Hedge Funds Review 'Best Group' in both 2008 and 2007. www.liongatecapital.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und